What are the Challenges of Using siRNA in Pediatric Patients?
Administering siRNA in pediatric patients presents several challenges. One of the primary obstacles is the delivery of siRNA to the target cells without degradation by nucleases or eliciting an immune response. Additionally, the developing bodies of children may react differently to siRNA-based therapies compared to adults, necessitating careful dosage and monitoring.
